TY - JOUR AU - Teker, Melike Elif AU - Teskin, Önder PY - 2018/09/25 Y2 - 2024/03/28 TI - Primary Cardiac Sarcoma Remission after Surgery: 5-Years Follow-up: Case Report JF - The Heart Surgery Forum JA - HSF VL - 21 IS - 5 SE - DO - 10.1532/hsf.1936 UR - https://journal.hsforum.com/index.php/HSF/article/view/1936 SP - E401-E403 AB - <p class="p1"><span class="s1"><strong>Background:</strong> Primary cardiac sarcoma is a rare and atypical clinical entity. We present a patient with long-term remission after primary cardiac sarcoma resection.</span></p><p class="p1"><span class="s2"><strong>Case Report:</strong> A 42-year-old previously healthy female presented to the emergency department after an effort-induced 30-minute episode of chest pain and extreme shortness of breath. Physical examination upon admission was remarkable for a pulse of 99/minute; blood pressure was 101/73 mmHg. Transthoracic echocardiography showed a mass measuring 5.5 × 5.6 cm extending from the left septum to the mitral valve anterior leaflet. A multilobulated broad-based 5.5 × 5.6 × 4 cm<sup>3</sup> mass invading a large portion of the left septum to the mitral valve anterior leaflet was completely excised in the open heart surgery. Chemotherapy regimen (paclitaxel 175 mg/m<sup>2</sup>/day on day 1, every 21 days) was started after operation. Full remission was provided. Metastasis and recurrence have not been observed for 5 years of follow-up by PET. We observed during 5 years and used a PET. And the finally we did not see metastasis at the 5 years of follow-up.</span></p><p class="p1"><span class="s2"><strong>Conclusions:</strong> We strongly recommend that a patient-specific multidisciplinary approach involving radical resection, chemotherapy, and radiation therapy in these cases results in patient survival and a significant improvement in quality of life. We also think that it is necessary to perform MRI to exclude other illnesses that are considered to be a myxoma.</span></p> ER -